We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
-27.19%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$7.34B
AUM Growth
-$3.86B
Cap. Flow
-$375M
Cap. Flow %
-5.12%
Top 10 Hldgs %
9.89%
Holding
1,223
New
86
Increased
388
Reduced
436
Closed
75

Top Buys

Rank Stock Value
1
ESE icon
ESCO Technologies
ESE
+$40.8M
2
HAE icon
Haemonetics
HAE
+$37.6M
3
ROG icon
Rogers Corp
ROG
+$26.2M
4
EVR icon
Evercore
EVR
+$25.5M
5
FARO
Faro Technologies
FARO
+$22M

Sector Composition

Rank Sector Weight
1 Industrials 25.72%
2 Technology 19.64%
3 Financials 14.17%
4 Consumer Discretionary 10.37%
5 Healthcare 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DZSI
626
DELISTED
DZS Inc. Common Stock
DZSI
$1.76M 0.02%
419,402
+205,046
+96% +$1.57M
LPTH icon
627
Lightpath Technologies
LPTH
$701M
$1.75M 0.02%
1,637,684
+173,800
+12% +$172K
VRA icon
628
Vera Bradley
VRA
$99M
$1.75M 0.02%
423,820
+42,544
+11% +$361K
CVA
629
DELISTED
Covanta Holding Corporation
CVA
$1.74M 0.02%
+203,500
New +$2.74M
PKG icon
630
Packaging Corp of America
PKG
$22.1B
$1.74M 0.02%
20,012
-17,961
-47% -$1.74M
TTEK icon
631
Tetra Tech
TTEK
$8.67B
$1.74M 0.02%
122,810
-24,040
-16% -$409K
VRT icon
632
Vertiv
VRT
$101B
$1.73M 0.02%
200,000
CNMD icon
633
CONMED
CNMD
$1.56B
$1.72M 0.02%
30,000
+1,000
+3% +$92.2K
CLAR icon
634
Clarus
CLAR
$126M
$1.71M 0.02%
175,704
LGTY
635
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$1.71M 0.02%
120,352
-2,374
-2% -$35.1K
APOG icon
636
Apogee Enterprises
APOG
$861M
$1.7M 0.02%
81,727
-65,626
-45% -$1.92M
ALOT icon
637
AstroNova
ALOT
$224M
$1.7M 0.02%
218,500
+29,000
+15% +$335K
CASS icon
638
Cass Information Systems
CASS
$722M
$1.66M 0.02%
47,260
+141
+0.3% +$6.81K
NGNE icon
639
Neurogene
NGNE
$659M
$1.66M 0.02%
7,270
CVU icon
640
CPI Aerostructures
CVU
$64.9M
$1.65M 0.02%
732,366
CSLT
641
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$1.62M 0.02%
2,239,034
+115,000
+5% +$128K
WDFC icon
642
WD-40
WDFC
$3.06B
$1.61M 0.02%
8,029
-1,331
-14% -$251K
FLG
643
Flagstar Bank National Association
FLG
$5.95B
$1.59M 0.02%
56,551
HOLI
644
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
$1.59M 0.02%
123,431
OZK icon
645
Bank OZK
OZK
$5.64B
$1.59M 0.02%
95,272
VOXX
646
DELISTED
VOXX International Corporation Class A
VOXX
$1.59M 0.02%
557,582
-229,357
-29% -$847K
EIC
647
Eagle Point Income Co
EIC
$231M
$1.58M 0.02%
148,128
-11,749
-7% -$202K
CVLY
648
DELISTED
Codorus Valley Bancorp Inc
CVLY
$1.57M 0.02%
97,522
-12,046
-11% -$245K
RBBN icon
649
Ribbon Communications
RBBN
$373M
$1.57M 0.02%
517,384
-487,631
-49% -$1.47M
NUS icon
650
Nu Skin
NUS
$252M
$1.56M 0.02%
71,347
+1
+0% +$30

Similar funds

Royce & Associates's Q1 2020 Portfolio in Review

As of Q1 2020, Royce & Associates held 1,223 positions worth $7.34B, down 34% from $11.2B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Royce & Associates withdrew a net $375M in Q1 2020, closing 75 positions and reducing 436 holdings. Its most notable exit was AVX Corporation, an estimated $71.1M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Royce & Associates opened a new position in ESCO Technologies worth $33.9M.

  • Royce & Associates's largest Q1 2020 buy was ESCO Technologies: 447,118 shares worth $33.9M.
  • Royce & Associates added most to Haemonetics in Q1 2020, an estimated $37.6M increase.
  • Royce & Associates's biggest Q1 2020 reduction was Virtu Financial, cutting an estimated $51M.
  • Royce & Associates fully exited AVX Corporation in Q1 2020, selling an estimated $71.1M.
  • Royce & Associates's ten largest holdings make up 9.9% of its $7.34B portfolio in Q1 2020.
  • Royce & Associates opened 86 new positions and closed 75 in Q1 2020.
  • Royce & Associates's portfolio value fell 34% quarter-over-quarter to $7.34B.

Based on Royce & Associates's 13F filing for Q1 2020, filed 12 May 2020.